Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Recommendations

Info

20. Addictive Disorders in Women 453Weisner, C., & Schmidt, L. (1992). Gender disparities in treatment for alcohol problems.JAMA, 268(14), 1872–1876.White, K. A., Brady, K. T., & Sonne, S. (1996). Gender differences in patterns ofcocaine use. Am J Addict, 5(3), 259–261.Zilberman, M. L., & Blume, S. B. (2004). Drugs and women. In J. Lowinson, P. Ruiz, R.B. Millman, & J. G. Langrodet (Eds.), Substance abuse: A comprehensive textbook(4th ed., pp. 1064–1079). Philadelphia: Lippincott/Williams & Wilkins.Zilberman, M. L., Tavares, H., Blume, S. B., & el-Guebaly, N. (2003). Substance usedisorders: Sex differences in psychiatric comorbidities. Can J Psychiatry, 48(1), 5–15.
Page 2:
CLINICAL TEXTBOOK OF ADDICTIVE DISO
Page 5 and 6:
© 2005 The Guilford PressA Divisio
Page 7 and 8:
viAbout the EditorsMedical College.
Page 9 and 10:
viiiContributorsStephen L. Dilts, M
Page 11 and 12:
xContributorsRussell K. Portenoy, M
Page 13 and 14:
xiiPrefaceof alcohol in the 2002 su
Page 15 and 16:
xivPrefaceResearch (1) on health sy
Page 18 and 19:
ContentsPART I. FOUNDATIONS OF ADDI
Page 20:
ContentsxixPART V. TREATMENTS FOR A
Page 24 and 25:
CHAPTER 1The Neurobiologyof Substan
Page 26 and 27:
1. The Neurobiology of Substance De
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
2. Historical and Social Context 17
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 55 and 56:
34 I. FOUNDATIONS OF ADDICTIONThomp
Page 58 and 59:
CHAPTER 3Psychological Evaluationof
Page 60 and 61:
3. Psychological Evaluation 39sever
Page 62 and 63:
3. Psychological Evaluation 41neuro
Page 64 and 65:
3. Psychological Evaluation 43In su
Page 66 and 67:
3. Psychological Evaluation 45subst
Page 68 and 69:
3. Psychological Evaluation 47is im
Page 70 and 71:
3. Psychological Evaluation 49Self-
Page 72 and 73:
3. Psychological Evaluation 51decis
Page 74 and 75:
3. Psychological Evaluation 53Socia
Page 76 and 77:
3. Psychological Evaluation 55Behav
Page 78 and 79:
3. Psychological Evaluation 57socia
Page 80 and 81:
3. Psychological Evaluation 59Lezak
Page 82 and 83:
3. Psychological Evaluation 61Tarte
Page 84 and 85:
CHAPTER 4Laboratory Testingfor Subs
Page 86 and 87:
4. Laboratory Testing 65stance. It
Page 88 and 89:
4. Laboratory Testing 67tive in lab
Page 90 and 91:
4. Laboratory Testing 69Agency (USA
Page 92:
4. Laboratory Testing 71CONCLUSIOND
Page 96 and 97:
CHAPTER 5AlcoholEDGAR P. NACEAlcoho
Page 98 and 99:
5. Alcohol 77withdrawal symptoms, b
Page 100 and 101:
5. Alcohol 79Drug Abuse-DependenceA
Page 102 and 103:
5. Alcohol 81symptoms as schizophre
Page 104 and 105:
5. Alcohol 83show low incidences of
Page 106 and 107:
5. Alcohol 85the rate of eliminatio
Page 108 and 109:
5. Alcohol 87nisms. The symptoms of
Page 110 and 111:
5. Alcohol 89individual with a hist
Page 112 and 113:
5. Alcohol 91The small intestine sh
Page 114 and 115:
5. Alcohol 93alcohol’s effect of
Page 116 and 117:
5. Alcohol 95Bone marrow recovery w
Page 118 and 119:
5. Alcohol 97Female breast cancer s
Page 120 and 121:
5. Alcohol 99tion and management. P
Page 122 and 123:
5. Alcohol 101nervosa and alcohol u
Page 124 and 125:
5. Alcohol 103for alcohol-related p
Page 126 and 127:
CHAPTER 6TobaccoNORMAN HYMOWITZHIST
Page 128 and 129:
6. Tobacco 107geon General’s Advi
Page 130 and 131:
6. Tobacco 109Smokers are wrong abo
Page 132 and 133:
6. Tobacco 111significant substance
Page 134 and 135:
6. Tobacco 113exacerbate existing i
Page 136 and 137:
6. Tobacco 115Substance use, in gen
Page 138 and 139:
6. Tobacco 117cological aids (Fager
Page 140 and 141:
6. Tobacco 119ciently nonirritating
Page 142 and 143:
6. Tobacco 121particular reinforcin
Page 144 and 145:
6. Tobacco 123The results of a smal
Page 146 and 147:
6. Tobacco 125proaches to smoking c
Page 148 and 149:
6. Tobacco 127smoking, and to smoke
Page 150 and 151:
6. Tobacco 129.02) and the 300-mg g
Page 152 and 153:
6. Tobacco 131cholinergic bronchodi
Page 154 and 155:
6. Tobacco 133Green, D.E. (1980). B
Page 156 and 157:
6. Tobacco 135Orleans, C. T. (1993)
Page 158 and 159:
6. Tobacco 137Monograph No. 17, DHE
Page 160 and 161:
7. Opioids 139DEFINITIONSThe opioid
Page 162 and 163:
7. Opioids 141sion of control chara
Page 164 and 165:
TABLE 7.2. Opioid Withdrawal7. Opio
Page 166 and 167:
7. Opioids 145The concept of tolera
Page 168 and 169:
7. Opioids 147der with water, heat
Page 170 and 171:
7. Opioids 149overdose in a pregnan
Page 172 and 173:
7. Opioids 151who may inject from f
Page 174 and 175:
7. Opioids 153more methadone, possi
Page 176 and 177:
7. Opioids 155Bickel, W. K., Stitze
Page 178 and 179:
Marijuana, Hallucinogens,and Club D
Page 180 and 181:
8. Marijuana, Hallucinogens, and Cl
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
9. Cocaine and Stimulants 185among
Page 208 and 209:
9. Cocaine and Stimulants 187Cocain
Page 210 and 211:
9. Cocaine and Stimulants 189ited,
Page 212 and 213:
9. Cocaine and Stimulants 191postsy
Page 214 and 215:
9. Cocaine and Stimulants 193herita
Page 216 and 217:
9. Cocaine and Stimulants 195Kleber
Page 218 and 219:
9. Cocaine and Stimulants 197When c
Page 220 and 221:
9. Cocaine and Stimulants 199OBSTET
Page 222 and 223:
9. Cocaine and Stimulants 201guide
Page 224 and 225:
9. Cocaine and Stimulants 203Cognit
Page 226 and 227:
9. Cocaine and Stimulants 205tity i
Page 228 and 229:
9. Cocaine and Stimulants 207purifi
Page 230 and 231:
9. Cocaine and Stimulants 209ence n
Page 232 and 233:
9. Cocaine and Stimulants 211Brady,
Page 234 and 235:
9. Cocaine and Stimulants 213others
Page 236 and 237:
9. Cocaine and Stimulants 215Martin
Page 238 and 239:
9. Cocaine and Stimulants 217DHHS P
Page 240 and 241:
Sedatives/Hypnoticsand Benzodiazepi
Page 242 and 243:
10. Sedatives/Hypnotics and Benzodi
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
TABLE 10.1. Pharmacological Charact
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264:
PART IVSPECIAL POPULATIONS
Page 267 and 268:
246 IV. SPECIAL POPULATIONSThis con
Page 269 and 270:
248 IV. SPECIAL POPULATIONSin patie
Page 271 and 272:
250 IV. SPECIAL POPULATIONSdisorder
Page 273 and 274:
252 IV. SPECIAL POPULATIONSsample o
Page 275 and 276:
254 IV. SPECIAL POPULATIONSAntisoci
Page 277 and 278:
256 IV. SPECIAL POPULATIONS(Cloning
Page 279 and 280:
258 IV. SPECIAL POPULATIONSdrug is
Page 281 and 282:
260 IV. SPECIAL POPULATIONSneous us
Page 283 and 284:
262 IV. SPECIAL POPULATIONSamine an
Page 285 and 286:
264 IV. SPECIAL POPULATIONSor bupre
Page 287 and 288:
266 IV. SPECIAL POPULATIONSsonality
Page 289 and 290:
268 IV. SPECIAL POPULATIONS(2001).
Page 291 and 292:
270 IV. SPECIAL POPULATIONSTómasso
Page 293 and 294:
272 IV. SPECIAL POPULATIONSAddition
Page 295 and 296:
274 IV. SPECIAL POPULATIONStreatmen
Page 297 and 298:
276 IV. SPECIAL POPULATIONSOther Th
Page 299 and 300:
278 IV. SPECIAL POPULATIONSDIAGNOSI
Page 301 and 302:
280 IV. SPECIAL POPULATIONStransfer
Page 303 and 304:
282 IV. SPECIAL POPULATIONSSpecific
Page 305 and 306:
284 IV. SPECIAL POPULATIONSattendin
Page 307 and 308:
286 IV. SPECIAL POPULATIONSPHARMACO
Page 309 and 310:
288 IV. SPECIAL POPULATIONSdiagnose
Page 311 and 312:
290 IV. SPECIAL POPULATIONSimproved
Page 313 and 314:
292 IV. SPECIAL POPULATIONSwith nov
Page 315 and 316:
294 IV. SPECIAL POPULATIONSand abus
Page 317 and 318:
296 IV. SPECIAL POPULATIONSpatients
Page 319 and 320:
298 IV. SPECIAL POPULATIONSMahler,
Page 321 and 322:
300 IV. SPECIAL POPULATIONSPowell,
Page 323 and 324:
302 IV. SPECIAL POPULATIONSWeiss, R
Page 325 and 326:
304 IV. SPECIAL POPULATIONSCORE FEA
Page 327 and 328:
306 IV. SPECIAL POPULATIONSThe asso
Page 329 and 330:
308 IV. SPECIAL POPULATIONSefficacy
Page 331 and 332:
TABLE 13.2. Double-Blind, Placebo-C
Page 333 and 334:
312 IV. SPECIAL POPULATIONSreceivin
Page 335 and 336:
314 IV. SPECIAL POPULATIONSLike ind
Page 337 and 338:
316 IV. SPECIAL POPULATIONSmomentar
Page 339 and 340:
318 IV. SPECIAL POPULATIONSChambers
Page 341 and 342:
320 IV. SPECIAL POPULATIONSorders.
Page 343 and 344:
322 IV. SPECIAL POPULATIONSican wom
Page 345 and 346:
324 IV. SPECIAL POPULATIONSamounts
Page 347 and 348:
326 IV. SPECIAL POPULATIONSLiteratu
Page 349 and 350:
328 IV. SPECIAL POPULATIONStrol and
Page 351 and 352:
330 IV. SPECIAL POPULATIONS& Fein,
Page 353 and 354:
332 IV. SPECIAL POPULATIONSAsian pr
Page 355 and 356:
334 IV. SPECIAL POPULATIONSBaker, F
Page 357 and 358:
336 IV. SPECIAL POPULATIONSGraves,
Page 359 and 360:
338 IV. SPECIAL POPULATIONSDifferen
Page 361 and 362:
CHAPTER 15Addictions in the Workpla
Page 363 and 364:
342 IV. SPECIAL POPULATIONSOrganiza
Page 365 and 366:
344 IV. SPECIAL POPULATIONSStimulan
Page 367 and 368:
346 IV. SPECIAL POPULATIONSemployer
Page 369 and 370:
348 IV. SPECIAL POPULATIONSshould b
Page 371 and 372:
350 IV. SPECIAL POPULATIONSstances,
Page 373 and 374:
352 IV. SPECIAL POPULATIONSbe halte
Page 375 and 376:
CHAPTER 16Addiction and the LawAVRA
Page 377 and 378:
356 IV. SPECIAL POPULATIONSobjected
Page 379 and 380:
358 IV. SPECIAL POPULATIONSOver tim
Page 381 and 382:
360 IV. SPECIAL POPULATIONSDisabili
Page 383 and 384:
362 IV. SPECIAL POPULATIONSdrawal f
Page 385 and 386:
364 IV. SPECIAL POPULATIONSStates h
Page 387 and 388:
366 IV. SPECIAL POPULATIONSMcClella
Page 389 and 390:
368 IV. SPECIAL POPULATIONSThe expa
Page 391 and 392:
370 IV. SPECIAL POPULATIONSThere co
Page 393 and 394:
372 IV. SPECIAL POPULATIONSTABLE 17
Page 395 and 396:
374 IV. SPECIAL POPULATIONScommon m
Page 397 and 398:
376 IV. SPECIAL POPULATIONSstand th
Page 399 and 400:
378 IV. SPECIAL POPULATIONSapproach
Page 401 and 402:
380 IV. SPECIAL POPULATIONS1. What
Page 403 and 404:
TABLE 17.5. Opioid AsnalgesicsEquia
Page 405 and 406:
384 IV. SPECIAL POPULATIONSadminist
Page 407 and 408:
386 IV. SPECIAL POPULATIONSas methy
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
392 IV. SPECIAL POPULATIONSArner, S
Page 415 and 416:
394 IV. SPECIAL POPULATIONSPassik,
Page 417 and 418:
CHAPTER 18Alcoholism and Substance
Page 419 and 420:
398 IV. SPECIAL POPULATIONSdrug eff
Page 421 and 422:
400 IV. SPECIAL POPULATIONSI (Zimbe
Page 423 and 424: 402 IV. SPECIAL POPULATIONSAlcohol-
Page 425 and 426: 404 IV. SPECIAL POPULATIONSStaffing
Page 427 and 428: 406 IV. SPECIAL POPULATIONSLocation
Page 429 and 430: 408 IV. SPECIAL POPULATIONSREFERENC
Page 431 and 432: 410 IV. SPECIAL POPULATIONSSurock,
Page 433 and 434: 412 IV. SPECIAL POPULATIONSfueling
Page 435 and 436: 414 IV. SPECIAL POPULATIONSLipton &
Page 437 and 438: 416 IV. SPECIAL POPULATIONSCo-abuse
Page 439 and 440: 418 IV. SPECIAL POPULATIONSsion. We
Page 441 and 442: 420 IV. SPECIAL POPULATIONSand the
Page 443 and 444: 422 IV. SPECIAL POPULATIONSthe immu
Page 445 and 446: 424 IV. SPECIAL POPULATIONSothers w
Page 447 and 448: 426 IV. SPECIAL POPULATIONSfuture p
Page 449 and 450: 428 IV. SPECIAL POPULATIONSand sex-
Page 451 and 452: 430 IV. SPECIAL POPULATIONSCole, S.
Page 453 and 454: 432 IV. SPECIAL POPULATIONSto reten
Page 455 and 456: 434 IV. SPECIAL POPULATIONSSheridan
Page 457 and 458: 436 IV. SPECIAL POPULATIONSDrug use
Page 459 and 460: 438 IV. SPECIAL POPULATIONSthe trea
Page 461 and 462: 440 IV. SPECIAL POPULATIONSweight),
Page 463 and 464: 442 IV. SPECIAL POPULATIONSin misca
Page 465 and 466: 444 IV. SPECIAL POPULATIONSdiagnose
Page 467 and 468: 446 IV. SPECIAL POPULATIONSCLINICAL
Page 469 and 470: 448 IV. SPECIAL POPULATIONSTABLE 20
Page 471 and 472: 450 IV. SPECIAL POPULATIONSREFERENC
Page 473: 452 IV. SPECIAL POPULATIONSand phys
Page 478 and 479: Individual PsychodynamicPsychothera
Page 480 and 481: 21. Individual Psychodynamic Psycho
Page 496 and 497: 22. Cognitive Therapy 475After list
Page 498 and 499: 22. Cognitive Therapy 477FIGURE 22.
Page 500 and 501: 22. Cognitive Therapy 479she also b
Page 502 and 503: 481FIGURE 22.4. Cognitive model of
Page 504 and 505: 22. Cognitive Therapy 483Therapists
Page 506 and 507: 22. Cognitive Therapy 485When patie
Page 508 and 509: 22. Cognitive Therapy 487Principle
Page 510 and 511: 22. Cognitive Therapy 489how to avo
Page 512 and 513: 22. Cognitive Therapy 491apy, they
Page 514 and 515: 22. Cognitive Therapy 493vigilant a
Page 516 and 517: 22. Cognitive Therapy 495Reducing D
Page 518 and 519: 22. Cognitive Therapy 497lengthy co
Page 520 and 521: 22. Cognitive Therapy 499behavioral
Page 522 and 523: 22. Cognitive Therapy 501Prochaska,
Page 524 and 525:
23. Group Therapy, Self-Help Groups
Page 526 and 527:
Page 528 and 529:
Educational Groups23. Group Therapy
Page 530 and 531:
Page 532 and 533:
Page 534 and 535:
Page 536 and 537:
Page 538 and 539:
Page 540 and 541:
Page 542 and 543:
Page 544 and 545:
Page 546 and 547:
Page 548 and 549:
Page 550 and 551:
24. Family-Based Treatment 529is th
Page 552 and 553:
24. Family-Based Treatment 531cated
Page 554 and 555:
24. Family-Based Treatment 533calle
Page 556 and 557:
24. Family-Based Treatment 535From
Page 558 and 559:
24. Family-Based Treatment 537lies,
Page 560 and 561:
24. Family-Based Treatment 539home
Page 562 and 563:
24. Family-Based Treatment 541drawa
Page 564 and 565:
24. Family-Based Treatment 543fears
Page 566 and 567:
24. Family-Based Treatment 545chemi
Page 568 and 569:
24. Family-Based Treatment 547SPECI
Page 570 and 571:
24. Family-Based Treatment 549(Stan
Page 572 and 573:
24. Family-Based Treatment 551tion
Page 574 and 575:
24. Family-Based Treatment 553Bepko
Page 576 and 577:
24. Family-Based Treatment 555Landa
Page 578 and 579:
24. Family-Based Treatment 557Stant
Page 580 and 581:
CHAPTER 25Treating Adolescent Subst
Page 582 and 583:
25. Adolescent Substance Abuse 561o
Page 584 and 585:
25. Adolescent Substance Abuse 563I
Page 586 and 587:
25. Adolescent Substance Abuse 565P
Page 588 and 589:
25. Adolescent Substance Abuse 5671
Page 590 and 591:
25. Adolescent Substance Abuse 569d
Page 592 and 593:
25. Adolescent Substance Abuse 571A
Page 594 and 595:
25. Adolescent Substance Abuse 573t
Page 596 and 597:
25. Adolescent Substance Abuse 575b
Page 598 and 599:
25. Adolescent Substance Abuse 577d
Page 600 and 601:
25. Adolescent Substance Abuse 579(
Page 602 and 603:
25. Adolescent Substance Abuse 581D
Page 604 and 605:
25. Adolescent Substance Abuse 583t
Page 606 and 607:
25. Adolescent Substance Abuse 585(
Page 608 and 609:
25. Adolescent Substance Abuse 587W
Page 610 and 611:
26. Psychopharmacological Treatment
Page 612 and 613:
Page 614 and 615:
Page 616 and 617:
Page 618 and 619:
Page 620 and 621:
Clonidine detoxification (9-day pro
Page 622 and 623:
Page 624 and 625:
Page 626 and 627:
TABLE 26.1. (continued)Indication26
Page 628 and 629:
Page 630 and 631:
Page 632 and 633:
Page 634 and 635:
Page 636 and 637:
CHAPTER 27Dialectical Behavior Ther
Page 638 and 639:
27. Dialectical Behavior Therapy 61
Page 640 and 641:
Page 642 and 643:
Page 644 and 645:
Page 646 and 647:
Page 648 and 649:
Page 650 and 651:
Page 652 and 653:
Page 654 and 655:
Page 656 and 657:
Page 658 and 659:
CHAPTER 28Matching and Differential
Page 660 and 661:
28. Matching and Differential Thera
Page 662 and 663:
Page 664 and 665:
Page 666 and 667:
Page 668 and 669:
Page 670 and 671:
Other Psychotherapies28. Matching a
Page 672 and 673:
Page 674 and 675:
Cognitive-Behavioral Therapies28. M
Page 676 and 677:
Page 678 and 679:
Page 680 and 681:
Page 682 and 683:
Page 684 and 685:
IndexAcamprosate, 405, 595Acetaldeh
Page 686 and 687:
Index 665dietary guidelines, 75-76e
Page 688 and 689:
Index 667pharmacotherapy with duall
Page 690 and 691:
Index 669Comorbidity, psychiatric,
Page 692 and 693:
Index 671Economics, 28-29alcohol us
Page 694 and 695:
Index 673Hinterpersonal problem-sol
Page 696 and 697:
Index 675personal injury cases, 359
Page 698 and 699:
Index 677in impulse control disorde
Page 700 and 701:
Index 679in family therapy, 549-550
Page 702 and 703:
Index 681Relapse and relapse preven
Page 704 and 705:
Index 683environmental tobacco smok
show all

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?